Demir Caner F, Balduz Metin, Taşcı İrem, Kuloğlu Tuncay
Department of Neurology, Firat University School of Medicine, Elazig, Turkey.
Department of Neurology, Çukurova State Hospital, Adana, Turkey.
Diabetol Int. 2020 Nov 16;12(2):207-216. doi: 10.1007/s13340-020-00476-0. eCollection 2021 Apr.
Diabetes mellitus (DM) is a metabolic disorder characterized by insulin deficiency or insulin resistance. Pregabalin (PGB) is an antiepileptic drug with proven efficacy in the treatment of epilepsy, generalized anxiety disorder, and neuropathic pain. In this study, we aimed to investigate the protective effects of PGB in brain tissue of rats with streptozotocin (STZ)-induced experimental diabetes.
Twenty-eight Wistar albino male rats were randomly divided into four groups with seven rats each: (I) Control group, (II) PGB (50 mg/kg PBG), (III) DM, and (IV) DM + PGB (50 mg/kg/day PGB per orally for 8 weeks). Diabetes was induced with an intraperitoneal (i.p.) STZ injection (Sigma Chemical Co Louis Missour, USA) at a dose of 180 mg/kg. STZ was dissolved in 0.1 M phosphate-citrate tampon (pH 4.5). Paraffin sections were examined using histological and immunohistochemical analyses. To detect oxidative damage biochemically, malondialdehyde (MDA), the end product of lipid peroxidation; superoxide dismutase (SOD), catalase (CAT), glutathione (GSH) and glutathione peroxidase (GPx) which are antioxidant enzymes, levels were studied. In addition, bax, caspase-3 enzyme activities and TUNEL assay were studied to evaluate the apoptosis status.
In the DM group, MDA concentrations were significantly higher and GPx and SOD activities were significantly lower compared to the control group. MDA concentrations were significantly lower and SOD activity was significantly higher in the DM + PGB group than in the DM group. The GPx activity in the DM group decreased significantly compared to the control group. In immunohistochemical examinations (Bax, Caspase-3 and TUNEL), the apoptosis rate was significantly lower in the in DM + PGB group than in the DM group.
Pregabalin may prevent harmful effects of oxidative damage by decreasing the MDA levels and increasing the SOD levels. In addition, it was thought that PGB may have antiapoptotic properties due to decreased bax and caspase-3 immunoreactivity and TUNEL positivity in PGB groups. Based on these findings, we think that PGB may be effective in reducing the risk of brain damage associated with DM.
糖尿病(DM)是一种以胰岛素缺乏或胰岛素抵抗为特征的代谢紊乱疾病。普瑞巴林(PGB)是一种抗癫痫药物,已证实其在治疗癫痫、广泛性焦虑症和神经性疼痛方面有效。在本研究中,我们旨在探讨普瑞巴林对链脲佐菌素(STZ)诱导的实验性糖尿病大鼠脑组织的保护作用。
28只雄性Wistar白化大鼠随机分为四组,每组7只:(I)对照组,(II)普瑞巴林组(50mg/kg PBG),(III)糖尿病组,(IV)糖尿病+普瑞巴林组(每天口服50mg/kg普瑞巴林,共8周)。通过腹腔注射(i.p.)180mg/kg的链脲佐菌素(Sigma Chemical Co Louis Missour,美国)诱导糖尿病。链脲佐菌素溶解于0.1M磷酸盐 - 柠檬酸盐缓冲液(pH 4.5)中。使用组织学和免疫组织化学分析检查石蜡切片。为了生化检测氧化损伤,研究了脂质过氧化终产物丙二醛(MDA)以及抗氧化酶超氧化物歧化酶(SOD)、过氧化氢酶(CAT)、谷胱甘肽(GSH)和谷胱甘肽过氧化物酶(GPx)的水平。此外,研究了bax、caspase - 3酶活性和TUNEL检测以评估细胞凋亡状态。
与对照组相比,糖尿病组的MDA浓度显著升高,GPx和SOD活性显著降低。糖尿病+普瑞巴林组的MDA浓度显著低于糖尿病组,SOD活性显著高于糖尿病组。糖尿病组的GPx活性与对照组相比显著降低。在免疫组织化学检查(Bax、Caspase - 3和TUNEL)中,糖尿病+普瑞巴林组的细胞凋亡率显著低于糖尿病组。
普瑞巴林可能通过降低MDA水平和提高SOD水平来预防氧化损伤的有害影响。此外,由于普瑞巴林组中bax和caspase - 3免疫反应性降低以及TUNEL阳性率降低,认为普瑞巴林可能具有抗凋亡特性。基于这些发现,我们认为普瑞巴林可能有效降低与糖尿病相关的脑损伤风险。